NCT00915694 2019-04-23
Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
Abramson Cancer Center at Penn Medicine
Phase 1 Terminated
Clinical Trials
3 trialsNCT01020292 2019-04-12
A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00694837 2015-04-10
Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
Maastricht Radiation Oncology
Phase 1 Completed